BiomX Inc.

NYSE:PHGE

Biological Products, (No Diagnostic Substances)·DOVER, DE

CFO

Wolfson Marina

Summary Financials

Revenue

—

Adj. EBITDA

-$42.0M

FY 2025

Net Income

-$17.7M

FY 2025

EPS (Diluted)

$58.31

FY 2025

Stock Price

$7.42

+9.0%

2026-03-09

52W Range

$1.50 – $14.71

P/E Ratio

0.1x

Market Cap

$11.8M

Cash

$16.9M

FY 2025

Total Debt

$5.8M

FY 2024

Net Cash

$11.1M

FY 2024

Enterprise Value

$746,276.26

Debt / EBITDA

0.3x

FY 2025

EV / EBITDA

-0.0x

Employees

—

Revenue

—

Adj. EBITDA

-$42.0M

FY 2025

Net Income

-$17.7M

FY 2025

EPS (Diluted)

$58.31

FY 2025

Stock Price

$7.42

+9.0%

2026-03-09

52W Range

$1.50 – $14.71

P/E Ratio

0.1x

Market Cap

$11.8M

Cash

$16.9M

FY 2025

Total Debt

$5.8M

FY 2024

Net Cash

$11.1M

FY 2024

Enterprise Value

$746,276.26

Debt / EBITDA

0.3x

FY 2025

EV / EBITDA

-0.0x

Employees

—